Heart Failure 2016

21 - 24 May 2016, Florence - Italy

Session Details

Targeting mitochondria to improve outcomes in heart failure
Sun 22 May 12:45 - 13:45 Cell Signalling Satellite Symposium Paris -
Chairpersons: Bertram PITT (Ann Arbor, United States of America), Marco METRA (Brescia, Italy)
Subtitle: Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Stealth Peptides
Learning Objectives: The learning objectives are as follow: To review the role of mitochondrial function in the pathogenesis of heart failure. To understand the role of new therapeutic approaches in improving mitochondrial structure and function. To focus on elamipretide in heart failure with preserved ejection fraction. To discuss new therapeutic approaches linking mitochondria and heart failure.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
12:45685Reaching the next level of drug development for heart failure: targetting mitochondria.Stefan ANKER (Gottingen, Germany)
13:00686Elamipretide improves mitochondrial activity in the failing human heart.Brian STAUFFER (Aurora, United States of America)
13:15687Elamipretide in heart failure with reduced ejection fraction.Hani SABBAH (Detroit, United States of America)
13:30688Clinical development concepts targeting mitochondria.Bertram PITT (Ann Arbor, United States of America)